Silencing of an endogenous target gene was evaluated with antibody based immunofluorescence detection of integrin alpha-5 (ITGA5) in PC-3 prostate cancer cells transfected for 48 h on a CSMA with replicate spots of a validated ITGA5 siRNA. The gene discussed is ITGA5; the disease is prostate cancer.